It is now almost common sense to say that social media affects how people feel about their appearance. We scroll through edited faces, idealized bodies, cosmetic transformations, fitness routines, and carefully staged... Read more »
What you’re calling imposter syndrome isn’t a syndrome, and it might not even be the problem you think it is. In 1978, psychologists Pauline R. Clance and Suzanne Imes introduced the concept,... Read more »
“A Freudian slip is when you say one thing but mean your mother.” Most of us have heard this saying and laughed. Although some psychological theories have overemphasized the mother’s role in... Read more »
A landmark nationwide cohort study has shed new light on how systemic factors and biological timelines influence attention deficit hyperactivity disorder (ADHD) diagnoses. By analyzing data from 66,146 incident ADHD patients and... Read more »
New research on hope and mindfulness by Feldman, Shapiro, and Dreher (2026) sheds fresh light on complementary connections between two behaviors that are consistently linked to psychological well-being. These findings suggest that... Read more »
Researchers recently conducted a comprehensive thematic synthesis. This specific methodology allowed them to pool qualitative data from 21 separate empirical studies involving 397 adults globally. By systematically gathering first-hand testimonies, the research... Read more »
I had a traumatic birth and postpartum anxiety. My husband withdrew and got quieter for months after. Only one of us got screened. Here’s what I’ve learned since. Source link Read more »
Dating today is hard. There is a haphazard quality to it. People are mindlessly swiping and liking, matching and un-matching, and messaging and then ghosting. Singles are feeling burnt out and jaded... Read more »
Since first watching the documentary “Anxiety Club,” I have written several articles inspired by both the film itself and the amazing conversations it has sparked. Directed and produced by Wendy Lobel, the... Read more »
At present, two drugs have been approved in the United States for people with early Alzheimer’s disease: donanemab and lecanemab. Unlike older drugs, which only addressed symptoms, the new options target and... Read more »